PG Related FDA
-
Procter & Gamble (PG), Teva (TEVA) Enter Multi-Billion Branded OTC Joint Venture
-
Somaxon (SOMX) Rips Higher Following FDA Meeting on Silenor OTC Program
-
Somaxon (SOMX) Gets Silenor Guidance from FDA in OTC Development; Appoints New Sales SVP
-
Procter & Gamble (PG), Teva (TEVA) Form Multi-Billion OTC Partnership
-
Somaxon Pharma (SOMX) Enters Into Silenor Co-Promotion Agreement with Proctor & Gamble (PG)
-
P&G (PG) Voluntarily Recalls Dayquil Cold & Flu 24-Count Liquicaps
-
The Alliance for Better Bone Health Reports FDA Approves Once-a-Month Dose of Actonel
-
Palomar Medical Technologies (PMTI) Receives 510(k) Clearance for Light-Based Hair Removal Device
-
Nastech (NSTK) Provides Update on Parathyroid Hormone, P&G Amends Contract
-
Procter & Gamble (PG) Provides Positive Data Based on Results from the ASCEND I and II studies
-
FDA Approves Procter & Gamble's (PG) Actonel for Treatment to Increase Bone Mass in Men with Osteoporosis
-
Procter & Gamble (PG) Announces Strategic Alliance with ARYx Therapeutics
-
Nastech Pharmaceutical (NSTK) Receives $7 Million Milestone Payment from Procter & Gamble (PG)
-
Nastech Pharma (NSTK) Receives $7 Million Milestone Payment from Procter & Gamble
-
Nastech (NSTK) In Supply Agreement with Procter & Gamble (PG) for osteoporosis Nasal Spray
-
Proctor & Gamble's (PG) Asacol was Well-Tolerated and Inducesd Rapid Mucosal Healing
-
NSTK and PG in Collaboration to Develop Nasal Spray Treatment of Osteoporosis
Back to PG Stock Lookup
